Zobrazeno 1 - 10
of 501
pro vyhledávání: '"M. Gaster"'
Opposition control of artificially initiated turbulent spots in a laminar boundary layer was carried out in a low-turbulence wind tunnel with the aim to delay transition to turbulence by modifying the turbulent structure within the turbulent spots. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56fd6b038ffdfcb72b10bdaef6242828
Autor:
J. Kim, R. Zhang, M. Kassem, M. Torabi Rahvar, B. Altinok, T. Barington, M. Jeddi-Tehrani, R. McKenzie, H. Yang, Y. Obata, G. Kumar, R. McIntosh, J. Kato, T. Ben Othman, H. Nakauchi, H. Hisha, J. Baran, K. Shimoji, S. Mise-Omata, A. Zarnani, J. Moon, F. Bojin, M. Gaster, Y. S. Lee, S. Darzi, S. Kazemnejad, J. Joh, M. Bejaoui, H. Wada, X. Wang, A. Abdelkafi, H. J. Sabir, Q. Li, L. Pulaski, J. O. Nehlin, C. Tatu, H. Suzukiand, F. Mallouli, M. Akhondi, F. Jenhani, N. Ben Azouna, I. Siska, T. S. Doi, N. Nishio, A. Walczak-Drzewiecka, K. Isobe, K. Seino, M. Stec, S. Kim, K. Entezami, M. Ratajewski, C. Bunu Panaitescu, J. Hwang, B. Ishizuka, A. Karadag, S. Kojo, T. Mizokami, A. Sunguroglu, H. Kanzaki, Y. Sato, N. Okamoto, B. Mytar, H. Chelli, Z. Cheng, T. Ozkan, V. Anderson, S. Aydos, A. Isa, V. Paunescu, Y. Choi, T. Yamaguchi, A. Wood, G. Tanasie, A. Karabay, T. Fukazawa, D. Nistor, S. Ito, J. Domenech, T. Andersen, S. Bozkurt, J. Dastych, M. Zembala, S. Ikehara
Publikováno v:
International Immunology. 22:i76-i79
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peter Ham, J V Selkirk, Frank E. Blaney, Susannah Davies, L M Gaster, David Malcolm Duckworth, John M. Hatcher, Derek N. Middlemiss, Gary W. Price, Frank King, P. D. Slade, Jim J. Hagan, Wyman Paul Adrian, Graham Francis Joiner, Claire Roberts, Sarah Margaret Jenkins, Carol Routledge, Keith Raymond Mulholland, Riley Gj, Andrew John Jennings, B. J. Jones
Publikováno v:
Journal of Medicinal Chemistry. 41:1218-1235
5-HT1 receptors are members of the G-protein-coupled receptor superfamily and are negatively linked to adenylyl cyclase activity. The human 5-HT1B and 5-HT1D receptors (previously known as 5-HT1Dbeta and 5-HT1Dalpha, respectively), although encoded b
Autor:
Gareth J. Sanger, Laramie M Gaster
Publikováno v:
Expert Opinion on Therapeutic Patents. 4:323-332
(1994). Overview Central & Peripheral Nervous System: 5-HT4 receptor antagonists. Expert Opinion on Therapeutic Patents: Vol. 4, No. 4, pp. 323-332.
Autor:
Keith Raymond Mulholland, E.S. Ellis, S Starr, Andrew John Jennings, Wyman Paul Adrian, L M Gaster, Frank King, Graham Francis Joiner, Kay A. Wardle, Sh K Rahman
Publikováno v:
Journal of Medicinal Chemistry. 36:4121-4123
Publikováno v:
Diabetes. 50(6)
To gain further insight into the mechanisms underlying muscle insulin resistance, the influence of obesity and type 2 diabetes on GLUT4 immunoreactivity in slow and fast skeletal muscle fibers was studied. Through a newly developed, very sensitive me
Autor:
Stephen E. Clarke, G. E. Jones, Steven Mark Bromidge, David T. Davies, Wyman Paul Adrian, Peter Ham, Sean Lightowler, Derek N. Middlemiss, Saunders Dv, Brenda K. Trail, Holland, Keith Raymond Mulholland, Ian Thomson Forbes, Frank E. Blaney, Riley Gj, Thomas P. Blackburn, David Malcolm Duckworth, Guy A. Kennett, Steven Dabbs, Susannah Davies, L M Gaster, Frank King, Wood
Publikováno v:
Journal of medicinal chemistry. 43(6)
The evolution, synthesis, and biological activity of a novel series of 5-HT(2C) receptor inverse agonists are reported. Biarylcarbamoylindolines have been identified with excellent 5-HT(2C) affinity and selectivity over 5-HT(2A) receptors. In additio
Autor:
J V, Selkirk, C, Scott, M, Ho, M J, Burton, J, Watson, L M, Gaster, L, Collin, B J, Jones, D N, Middlemiss, G W, Price
Publikováno v:
British journal of pharmacology. 125(1)
1. Human 5-HT1B (h5-HT1B) and human 5-HT1D (h5-HT1D) receptors show remarkably similar pharmacology with few compounds discriminating the receptors. We report here on a novel compound, SB-224289 (1'-Methyl-5-[[2'-methyl-4'-(5-methyl- 1,2,4-oxadiazol-
Autor:
L M, Gaster, F D, King
Publikováno v:
Medicinal research reviews. 17(2)